Zealand Pharma A/S
CSE:ZEAL

Watchlist Manager
Zealand Pharma A/S Logo
Zealand Pharma A/S
CSE:ZEAL
Watchlist
Price: 726.5 DKK 4.23% Market Closed
Market Cap: 51.5B DKK
Have any thoughts about
Zealand Pharma A/S?
Write Note

Relative Value

The Relative Value of one ZEAL stock under the Base Case scenario is 174.29 DKK. Compared to the current market price of 726.5 DKK, Zealand Pharma A/S is Overvalued by 76%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ZEAL Relative Value
Base Case
174.29 DKK
Overvaluation 76%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
0
vs Industry
12
Median 3Y
86.6
Median 5Y
74.1
Industry
7.7
Forward
307.6
vs History
vs Industry
Median 3Y
-9.3
Median 5Y
-12.8
Industry
22.7
Forward
-52.3
vs History
vs Industry
Median 3Y
-14.2
Median 5Y
-14.2
Industry
21.6
vs History
vs Industry
Median 3Y
-10.4
Median 5Y
-11.4
Industry
25.2
vs History
46
vs Industry
4
Median 3Y
9.6
Median 5Y
6.9
Industry
2.5
vs History
0
vs Industry
10
Median 3Y
85.7
Median 5Y
73.2
Industry
7.7
Forward
259.1
vs History
0
vs Industry
7
Median 3Y
58.8
Median 5Y
58.8
Industry
9
vs History
vs Industry
Median 3Y
-15
Median 5Y
-12.8
Industry
4.2
Forward
-57.1
vs History
vs Industry
Median 3Y
-13.1
Median 5Y
-12.5
Industry
4.1
Forward
-59.2
vs History
vs Industry
Median 3Y
-13.6
Median 5Y
-12
Industry
5.7
vs History
vs Industry
Median 3Y
-13.4
Median 5Y
-11.3
Industry
3.6
vs History
15
vs Industry
0
Median 3Y
52.2
Median 5Y
31.3
Industry
4.6

Multiples Across Competitors

ZEAL Competitors Multiples
Zealand Pharma A/S Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
Zealand Pharma A/S
CSE:ZEAL
51.3B DKK 667.7 -48.8 -40 -38.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.2B USD 10.9 -242.3 24.1 25.3
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.3B USD 5.9 17.5 15.9 17.7
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.8B EUR 18.7 -131 -105.5 -76.9
P/E Multiple
Earnings Growth
DK
Zealand Pharma A/S
CSE:ZEAL
Average P/E: 208.2
Negative Multiple: -48.8
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -242.3
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.5
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -131 N/A
EV/EBITDA Multiple
EBITDA Growth
DK
Zealand Pharma A/S
CSE:ZEAL
Average EV/EBITDA: 17.2
Negative Multiple: -40
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.1
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.9
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.5 N/A
EV/EBIT Multiple
EBIT Growth
DK
Zealand Pharma A/S
CSE:ZEAL
Average EV/EBIT: 22.5
Negative Multiple: -38.4
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.3
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.7
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.9 N/A

See Also

Discover More
Back to Top